P360 Debuts Generative AI-Powered Information Platform to Help Life Sciences Companies Engage With HCPs and Patients

New platform provides HCPs and patients with real-time answers and access to current product information.

PISCATAWAY TOWNSHIP, NJ – September 12, 2023 -- P360, a leading developer of technology for life sciences companies, today announced the release of a new generative AI-powered information platform that enables pharmaceutical, device and other life sciences companies to provide healthcare professionals (HCPs) and patients with real-time answers and access to up-to-date product information. As part of its mission to continuously innovate, P360 is now enabling companies to extend their customer engagement capabilities through the use of generative AI.

"We believe this new platform will be the ultimate tool for companies that want to share the most current and accurate product information with healthcare professionals and patients alike," explained P360 CEO and co-founder Anupam Nandwana. "HCPs can search and find current product information, recommendations and specifications with ease. Additionally, HCPs, and even patients, can ask the system questions about products, their uses and much more, and receive correct, automated answers in real-time.”

The platform is based on a private large language model (LLM) to help ensure privacy, data security and integrity. Generative AI trained from a private LLM operates within a controlled environment, where the dataset is meticulously curated to align with specific guidelines, quality standards and desired outcomes. This same environment also prevents proprietary company data from entering the public domain.

“Unlike public LLMs, private LLMs run off of a company’s own data,” added Nandwana. “This significantly improves the accuracy of all outputs and helps companies remain in control of the data being used. And ultimately, it helps ensure compliance standards are being met.”

P360’s new generative AI-powered information platform integrates with all of P360’s products, including the powerful ZING Engagement Suite. ZING is a comprehensive and compliant solution that enhances existing communication channels with features including text message-based Chatbot assistance, live SMS messaging, Video conferencing, onscreen collaboration and form sharing, inbound communications with QR code scan, Part 11 compliant signature capture, easy access integrations and more.

P360’s new generative AI-powered information platform will be in Beta through December 2023. It will become generally available in January 2024. Those interested in the Beta release can request more information. For more about P360, visit P360.com.

About P360

Based in Piscataway Township, New Jersey, P360 is a leading technology developer for the life sciences industry. We specialize in technology that improves operational efficiency, enables end-to-end visibility, streamlines workflows and boosts customer engagement. Product offerings include the ZING Engagement Suite, BirdzAI, Swittons and Curotrak. To learn more about P360, visit P360.com.